Misleading ad case: Ramdev, Balkrishna tender 'unconditional' apology to SC

Patanjali Ayurved founder Ramdev and MD Balkrishna have submitted affidavits offering 'unconditional, unqualified' apologies to the Supreme Court

Ramdev
Ramdev
Rimjhim Singh New Delhi
3 min read Last Updated : Apr 10 2024 | 10:23 AM IST
Patanjali Ayurved's founder, Ramdev, and managing director (MD) Balkrishna have submitted affidavits to the Supreme Court, offering "unconditional, unqualified" apologies.

According to a report in The Economic Times, the duo said that they would comply with the order in letter and spirit and uphold the majesty of law and the majesty of justice. The SC is expected to deliver its final decision on the matter on Wednesday.

In the earlier hearing, the court had rejected the apology from yoga guru Ramdev and the firm's managing director Acharya Balkrishna over putting out misleading advertisements.

The Bench, headed by Justice Hima Kohli, had also questioned the Centre's inaction over Patanjali's claims about the efficacy of its products and denigrating allopathy during the Covid-19 peak. The Bench further said it was taking their apology with a "sack full of salt". The Bench warned Patanjali, Ramdev, and Balkrishna that it would take note of "perjury" as certain documents, which were said to be attached with other papers, were created later on.

The court stated: "This is a clear case of perjury. We are not closing the doors on you but we are telling all that we have noted."

According to the ET report, on November 21 last year, Patanjali Ayurved Ltd assured the top court that it would not violate any law, especially those relating to advertising or branding of the products manufactured and marketed by it. It also assured the Bench that "no casual statements claiming medicinal efficacy or against any system of medicine will be released to the media in any form".

The top court had said Patanjali Ayurved Ltd is "bound down to such assurance".

On Tuesday, the apex court disapproved Balkrishna's statement that the Drugs and Cosmetics (Magic Remedies) Act is "archaic" and Patanjali Ayurved's advertisements were in the "teeth of the Act" and violated the undertaking given to the court with impunity.

The Bench warned Ramdev and Balkrishna to be ready to face the consequences. "Your apology is not persuading this court really to accept it. We think it is more of a lip service," Justice Kohli said.

Justice Kohli said, "You have to abide by the undertaking given to the court. The purpose of contempt is to make a person realise that the majesty of the law is above all."

In response to the court's statements, senior advocate Vipin Sanghi, the counsel representing Patanjali, said the media department of the company was unaware of the fact that the top court had restrained it from continuing with advertisements or branding of products manufactured and marketed by it which are meant to cure diseases, according to the ET report.

"Mr Sanghi, once it is a court proceeding and there are specific undertakings given by you to the court. Whose duty is to convey it to the entire chain down the line?" Justice Kohli asked.

The Bench said the undertaking has to be abided by in letter and spirit.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Patanjali Ayurved RamdevRamdev's PatanjaliRamdevYoga Guru RamdevPatanjali AyurvedaPatanjaliPatanjali AyurvedBS Web ReportsAcharya Balkrishna

First Published: Apr 10 2024 | 10:23 AM IST

Next Story